Abrdn Healthcare Investors (NYSE:HQH - Get Free Report) was the target of a large drop in short interest during the month of October. As of October 15th, there was short interest totalling 67,000 shares, a drop of 37.3% from the September 30th total of 106,900 shares. Based on an average daily volume of 140,300 shares, the days-to-cover ratio is currently 0.5 days.
Abrdn Healthcare Investors Trading Up 0.1 %
Abrdn Healthcare Investors stock traded up $0.02 during mid-day trading on Friday, hitting $18.33. 69,698 shares of the company's stock traded hands, compared to its average volume of 115,463. The firm has a 50 day simple moving average of $18.72 and a two-hundred day simple moving average of $17.84. Abrdn Healthcare Investors has a fifty-two week low of $14.31 and a fifty-two week high of $19.79.
Abrdn Healthcare Investors Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Friday, August 23rd were issued a dividend of $0.59 per share. This represents a $2.36 annualized dividend and a yield of 12.88%. The ex-dividend date of this dividend was Friday, August 23rd.
Institutional Investors Weigh In On Abrdn Healthcare Investors
Hedge funds have recently added to or reduced their stakes in the business. Raymond James & Associates lifted its holdings in shares of Abrdn Healthcare Investors by 79.8% during the third quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider's stock worth $6,614,000 after buying an additional 157,618 shares in the last quarter. Cetera Investment Advisers lifted its holdings in shares of Abrdn Healthcare Investors by 46.8% during the first quarter. Cetera Investment Advisers now owns 177,208 shares of the financial services provider's stock worth $2,988,000 after buying an additional 56,521 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of Abrdn Healthcare Investors by 3.5% during the first quarter. Janney Montgomery Scott LLC now owns 162,986 shares of the financial services provider's stock worth $2,748,000 after buying an additional 5,489 shares in the last quarter. Cetera Advisors LLC acquired a new stake in shares of Abrdn Healthcare Investors during the first quarter worth $1,974,000. Finally, Oppenheimer & Co. Inc. lifted its holdings in shares of Abrdn Healthcare Investors by 16.8% during the first quarter. Oppenheimer & Co. Inc. now owns 113,387 shares of the financial services provider's stock worth $1,912,000 after buying an additional 16,318 shares in the last quarter. Institutional investors and hedge funds own 32.60% of the company's stock.
About Abrdn Healthcare Investors
(
Get Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
See Also
Before you consider Abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abrdn Healthcare Investors wasn't on the list.
While Abrdn Healthcare Investors currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
